Epididymal cystadenomas and epithelial tumourlets: Effects of VHL deficiency on the human epididymis

S. Gläsker, M. G.B. Tran, S. B. Shively, B. Ikejiri, R. R. Lonser, P. H. Maxwell, Z. Zhung, E. H. Oldfield, Alexander Vortmeyer

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Although epididymal cystadenomas (ECAs) are among the most frequent VHL disease-associated tumours, fundamental questions about their pathogenesis have remained unanswered. Classification of ECAs is controversial, and the cell of origin is unknown. It is also unknown whether ECAs - like other VHL disease-associated tumours - arise as a result of VHL gene inactivation, and whether ECAs exhibit subsequent activation of hypoxia-inducible factor HIF. Moreover, the morphological spectrum of earliest ECA formation is unknown. In a detailed molecular pathological analysis of a series of epididymides collected from VHL patients at autopsy, we found that ECAs are true neoplasms that arise secondary to inactivation of the wild-type copy of the VHL gene, followed by early and simultaneous activation of HIF1 and HIF2 associated with up-regulation of downstream targets, including CAIX and GLUT-1. The observations also indicate that ECA formation evolves from a variety of microscopic epithelial tumourlets, and that these tumourlets are confined to the efferent ductular system. Although genetic and immunohistochemical analysis of precursor structures consistently revealed VHL gene inactivation and activation of HIF in the precursor lesions, only a small subset appears to progress into frank cystadenoma. Thus, ECA tumorigenesis in VHL disease shares fundamental principles with tumorigenesis in other affected organ systems.

Original languageEnglish (US)
Pages (from-to)32-41
Number of pages10
JournalJournal of Pathology
Volume210
Issue number1
DOIs
StatePublished - Sep 1 2006
Externally publishedYes

Fingerprint

Cystadenoma
Epididymis
Gene Silencing
Carcinogenesis
Neoplasms
Transcriptional Activation
Autopsy
Up-Regulation

Keywords

  • Epididymis cystadenoma
  • Hypoxia-inducible factor
  • Tumour suppressor gene
  • von Hippel-Lindau disease

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Gläsker, S., Tran, M. G. B., Shively, S. B., Ikejiri, B., Lonser, R. R., Maxwell, P. H., ... Vortmeyer, A. (2006). Epididymal cystadenomas and epithelial tumourlets: Effects of VHL deficiency on the human epididymis. Journal of Pathology, 210(1), 32-41. https://doi.org/10.1002/path.2029

Epididymal cystadenomas and epithelial tumourlets : Effects of VHL deficiency on the human epididymis. / Gläsker, S.; Tran, M. G.B.; Shively, S. B.; Ikejiri, B.; Lonser, R. R.; Maxwell, P. H.; Zhung, Z.; Oldfield, E. H.; Vortmeyer, Alexander.

In: Journal of Pathology, Vol. 210, No. 1, 01.09.2006, p. 32-41.

Research output: Contribution to journalArticle

Gläsker, S, Tran, MGB, Shively, SB, Ikejiri, B, Lonser, RR, Maxwell, PH, Zhung, Z, Oldfield, EH & Vortmeyer, A 2006, 'Epididymal cystadenomas and epithelial tumourlets: Effects of VHL deficiency on the human epididymis', Journal of Pathology, vol. 210, no. 1, pp. 32-41. https://doi.org/10.1002/path.2029
Gläsker S, Tran MGB, Shively SB, Ikejiri B, Lonser RR, Maxwell PH et al. Epididymal cystadenomas and epithelial tumourlets: Effects of VHL deficiency on the human epididymis. Journal of Pathology. 2006 Sep 1;210(1):32-41. https://doi.org/10.1002/path.2029
Gläsker, S. ; Tran, M. G.B. ; Shively, S. B. ; Ikejiri, B. ; Lonser, R. R. ; Maxwell, P. H. ; Zhung, Z. ; Oldfield, E. H. ; Vortmeyer, Alexander. / Epididymal cystadenomas and epithelial tumourlets : Effects of VHL deficiency on the human epididymis. In: Journal of Pathology. 2006 ; Vol. 210, No. 1. pp. 32-41.
@article{4236fe36020e4c90a5bf7d43488910e5,
title = "Epididymal cystadenomas and epithelial tumourlets: Effects of VHL deficiency on the human epididymis",
abstract = "Although epididymal cystadenomas (ECAs) are among the most frequent VHL disease-associated tumours, fundamental questions about their pathogenesis have remained unanswered. Classification of ECAs is controversial, and the cell of origin is unknown. It is also unknown whether ECAs - like other VHL disease-associated tumours - arise as a result of VHL gene inactivation, and whether ECAs exhibit subsequent activation of hypoxia-inducible factor HIF. Moreover, the morphological spectrum of earliest ECA formation is unknown. In a detailed molecular pathological analysis of a series of epididymides collected from VHL patients at autopsy, we found that ECAs are true neoplasms that arise secondary to inactivation of the wild-type copy of the VHL gene, followed by early and simultaneous activation of HIF1 and HIF2 associated with up-regulation of downstream targets, including CAIX and GLUT-1. The observations also indicate that ECA formation evolves from a variety of microscopic epithelial tumourlets, and that these tumourlets are confined to the efferent ductular system. Although genetic and immunohistochemical analysis of precursor structures consistently revealed VHL gene inactivation and activation of HIF in the precursor lesions, only a small subset appears to progress into frank cystadenoma. Thus, ECA tumorigenesis in VHL disease shares fundamental principles with tumorigenesis in other affected organ systems.",
keywords = "Epididymis cystadenoma, Hypoxia-inducible factor, Tumour suppressor gene, von Hippel-Lindau disease",
author = "S. Gl{\"a}sker and Tran, {M. G.B.} and Shively, {S. B.} and B. Ikejiri and Lonser, {R. R.} and Maxwell, {P. H.} and Z. Zhung and Oldfield, {E. H.} and Alexander Vortmeyer",
year = "2006",
month = "9",
day = "1",
doi = "10.1002/path.2029",
language = "English (US)",
volume = "210",
pages = "32--41",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Epididymal cystadenomas and epithelial tumourlets

T2 - Effects of VHL deficiency on the human epididymis

AU - Gläsker, S.

AU - Tran, M. G.B.

AU - Shively, S. B.

AU - Ikejiri, B.

AU - Lonser, R. R.

AU - Maxwell, P. H.

AU - Zhung, Z.

AU - Oldfield, E. H.

AU - Vortmeyer, Alexander

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Although epididymal cystadenomas (ECAs) are among the most frequent VHL disease-associated tumours, fundamental questions about their pathogenesis have remained unanswered. Classification of ECAs is controversial, and the cell of origin is unknown. It is also unknown whether ECAs - like other VHL disease-associated tumours - arise as a result of VHL gene inactivation, and whether ECAs exhibit subsequent activation of hypoxia-inducible factor HIF. Moreover, the morphological spectrum of earliest ECA formation is unknown. In a detailed molecular pathological analysis of a series of epididymides collected from VHL patients at autopsy, we found that ECAs are true neoplasms that arise secondary to inactivation of the wild-type copy of the VHL gene, followed by early and simultaneous activation of HIF1 and HIF2 associated with up-regulation of downstream targets, including CAIX and GLUT-1. The observations also indicate that ECA formation evolves from a variety of microscopic epithelial tumourlets, and that these tumourlets are confined to the efferent ductular system. Although genetic and immunohistochemical analysis of precursor structures consistently revealed VHL gene inactivation and activation of HIF in the precursor lesions, only a small subset appears to progress into frank cystadenoma. Thus, ECA tumorigenesis in VHL disease shares fundamental principles with tumorigenesis in other affected organ systems.

AB - Although epididymal cystadenomas (ECAs) are among the most frequent VHL disease-associated tumours, fundamental questions about their pathogenesis have remained unanswered. Classification of ECAs is controversial, and the cell of origin is unknown. It is also unknown whether ECAs - like other VHL disease-associated tumours - arise as a result of VHL gene inactivation, and whether ECAs exhibit subsequent activation of hypoxia-inducible factor HIF. Moreover, the morphological spectrum of earliest ECA formation is unknown. In a detailed molecular pathological analysis of a series of epididymides collected from VHL patients at autopsy, we found that ECAs are true neoplasms that arise secondary to inactivation of the wild-type copy of the VHL gene, followed by early and simultaneous activation of HIF1 and HIF2 associated with up-regulation of downstream targets, including CAIX and GLUT-1. The observations also indicate that ECA formation evolves from a variety of microscopic epithelial tumourlets, and that these tumourlets are confined to the efferent ductular system. Although genetic and immunohistochemical analysis of precursor structures consistently revealed VHL gene inactivation and activation of HIF in the precursor lesions, only a small subset appears to progress into frank cystadenoma. Thus, ECA tumorigenesis in VHL disease shares fundamental principles with tumorigenesis in other affected organ systems.

KW - Epididymis cystadenoma

KW - Hypoxia-inducible factor

KW - Tumour suppressor gene

KW - von Hippel-Lindau disease

UR - http://www.scopus.com/inward/record.url?scp=33747876465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747876465&partnerID=8YFLogxK

U2 - 10.1002/path.2029

DO - 10.1002/path.2029

M3 - Article

C2 - 16841375

AN - SCOPUS:33747876465

VL - 210

SP - 32

EP - 41

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 1

ER -